About us
Who are we?
JunGlobal Healthcare Solutions Ltd is a healthcare, pharmaceutical, and business development consultancy firm dedicated to supporting both indigenous and international organizations in successfully entering, navigating, and scaling within the Nigerian and broader African markets.
We specialize in regulatory advisory, market access strategy, pharmaceutical marketing, hospital and institutional business (HIB) development, and commercialization execution—ensuring that products not only achieve regulatory approval but also attain sustainable market penetration, strong brand visibility, and long-term revenue growth.
Our approach is driven by market intelligence, research, and data analytics, enabling evidence-based decision-making across the full product value chain. We provide end-to-end support from product registration and positioning to lifecycle management, institutional engagement, distribution structuring, and post-launch performance optimization.
Integrated Capabilities
We provide healthcare supply chain management and strengthening services, supporting efficient product movement, institutional access, and availability across distribution channels, including collaboration with procurement agencies, DMAs, and healthcare providers.
We support our partners in building and strengthening brand visibility for both companies and products through strategic marketing frameworks, stakeholder engagement, and targeted communication within the healthcare ecosystem.
We deliver staff capacity building, field force training, and sales team coaching—equipping commercial and medical teams with the skills, knowledge, and strategic alignment required to drive product adoption, institutional engagement, and sustained market performance. We also support strategic talent acquisition, recruitment, and team structuring.
In addition to our commercial expertise, we design and implement public health programs and interventions, working with private sector organizations, government agencies, NGOs, and international development partners. Our capabilities include health systems strengthening, epidemiological research, and monitoring & evaluation (M&E) to ensure impactful and sustainable health outcomes.
Leadership
Her leadership in developing Hospital & Institutional Business (HIB) frameworks, driving product portfolio growth, and facilitating strategic healthcare partnerships positions the firm as a trusted partner for market entry and expansion.
*The Corporate Governance, Finance & Compliance function is led by a Chartered Accountant and Company Secretary responsible for financial management, audit, tax compliance, and corporate governance.
MISSION
To bridge the gap between healthcare innovation and market success by delivering integrated, data-driven solutions in pharmaceutical marketing, regulatory advisory, market access, commercialization, distribution and retail strategy, supply chain strengthening, and public health program implementation—enabling our partners to achieve sustainable growth while improving access to quality healthcare.
VISION
To be a leading African healthcare market access and commercialization firm, advancing access to quality healthcare through strong market systems, public health impact, strategic partnerships, and sustainable growth across the pharmaceutical value chain.
CORE VALUES
Excellence & Execution – We deliver high-quality, results-driven solutions with strong implementation focus
Integrity & Partnership – We build trusted, transparent, and collaborative relationships
Advocacy
Community Impact
Executive Experience & Achievements
Designed and implemented the Hospital & Institutional Business (HIB) framework, driving successful penetration of pharmaceutical products into hospitals, procurement systems, and institutional channels across Nigeria.
Spearheaded pharmaceutical product development and lifecycle management strategies, aligning market needs with commercial objectives to enhance product visibility, competitiveness, and long-term revenue performance.
Developed and led the execution of high-impact strategic marketing initiatives, including the Ceflonac SP 5-Year Strategic Marketing Plan (2022–2026), strengthening brand positioning and market share.
Conceptualized and led the Geneith Health Competition (GHC), a high-impact healthcare initiative that enhanced brand visibility, stakeholder engagement, and industry participation within the Nigerian healthcare ecosystem.
Facilitated strategic collaboration with the Africa Resource Center for Excellence in Supply Chain Management (ARC-ESM), States Drug Management Agencies (DMAs), and key stakeholders, strengthening supply chain access and institutional market reach.
Directed portfolio optimization strategies, identifying growth opportunities, managing product performance, and reducing overdependence on limited revenue streams.
Established and strengthened Customer Relationship Management (CRM) systems, improving data-driven engagement with healthcare professionals, institutions, and key stakeholders.
Led, trained, and supervised cross-functional marketing and HIB teams, driving performance, alignment with corporate objectives, and execution excellence.
Coordinated regulatory and stakeholder engagement activities with key bodies including NAFDAC, PCN, PMG-MAN, PSN, and government health institutions, supporting product registration, compliance, and market access.
Engaged and collaborated with multilateral and development organizations including WHO, WAHO, UNIDO, ECOWAS, IFC, and CDE on healthcare and pharmaceutical initiatives.
Partner with us today
Let’s work together to shape innovative healthcare solutions, strengthen pharmaceutical systems, and inspire healthier communities.